Clinical Trials Logo

Clinical Trial Summary

To determine the efficacy and safety of Botulax® in treatment of crow's feet line


Clinical Trial Description

1. Allocation: Randomized 2. Masking: Double Blind ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03408236
Study type Interventional
Source Hugel
Contact
Status Completed
Phase Phase 3
Start date January 17, 2018
Completion date June 7, 2019

See also
  Status Clinical Trial Phase
Completed NCT02248844 - Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
Completed NCT02195687 - BOTOX® in the Treatment of Crow's Feet Lines in China Phase 3
Completed NCT01189760 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT01189747 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines Phase 3
Recruiting NCT04081402 - A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines Phase 3
Completed NCT01224015 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02176356 - Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) Phase 4
Not yet recruiting NCT06402058 - A Study Comparing DMSB01 and Rejuran® for Temporary Crow's Feet Lines Improvement N/A
Completed NCT06376838 - To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet N/A
Not yet recruiting NCT03184363 - Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study) Phase 3
Completed NCT01797081 - BOTOX® in the Treatment of Crow's Feet Lines in Japan Phase 3
Completed NCT01797094 - BOTOX® in the Treatment of Upper Facial Lines in Japan Phase 3
Completed NCT03317574 - MEDITOXIN® in Treatment of Crow's Feet Line Phase 3